Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expectant Management Versus Medical Management of Retained Products of Conception After Induced Abortion

NCT04685694 is registered in ClinicalTrials.gov with Tel-Aviv Sourasky Medical Center as lead sponsor.

NCT NCT04685694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04685694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expectant Management Versus Medical Management of Retained Products of Conception After Induced Abortion
Lead sponsor
Tel-Aviv Sourasky Medical Center
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2020
Completion date
January 31, 2022
Enrollment
141 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abortion induced complicated